Karyopharm Therapeutics Inc. buy Piper Sandler
Start price
27.04.26
/
50%
€0.54
Target price
27.04.27
€13.64
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 27.04.27. The prediction end date can be changed by Piper_Sandler at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Karyopharm Therapeutics Inc. | - |
| iShares Core DAX® | -0.372% |
| iShares Nasdaq 100 | 2.269% |
| iShares Nikkei 225® | 1.433% |
| iShares S&P 500 | 1.216% |
Comments by Piper_Sandler for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics (KPTI) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $16.00 price target on the stock, up from $8.00.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Piper_Sandler for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
30.03.26
30.03.26
€6.95
30.03.27
30.03.27
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.12.25
17.12.25
-
17.12.26
17.12.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
09.10.25
09.10.25
€10.31
09.10.26
09.10.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.83
06.11.24
06.11.24
€4.67
06.11.25
06.11.25
-33.98%
07.11.25
07.11.25

